VICOR CORP·4

Mar 9, 4:08 PM ET

Davies Philip D 4

4 · VICOR CORP · Filed Mar 9, 2026

Research Summary

AI-generated summary of this filing

Updated

Vicor (VICR) VP Philip D. Davies Exercises Options & Sells 5,419 Shares

What Happened

  • Philip D. Davies, VP Global Sales & Marketing and a company director at Vicor (VICR), exercised three option tranches totaling 5,419 shares (1,920 @ $41.61; 2,585 @ $60.61; 914 @ $75.43) on 2026-03-05, paying roughly $305,511 in aggregate strike cost.
  • He then sold the 5,419 shares in multiple open-market transactions that same day for total proceeds of about $1,027,829. This sequence (exercise followed by sale) is effectively a cashing-out of option gains rather than a new purchase.

Key Details

  • Transaction date: 2026-03-05; Form 4 filed 2026-03-09 (timely filed).
  • Options exercised: 5,419 shares in three tranches (strike prices $41.61, $60.61, $75.43); aggregated exercise cost ≈ $305,511.
  • Open-market sales: 5,419 shares across many trades at prices ranging roughly from $177.18 to $202.26; proceeds ≈ $1,027,829. Several reported prices are weighted averages of multiple trades (see filing footnotes).
  • Notable footnotes: at least one sale was made pursuant to a Rule 10b5-1 trading plan adopted Nov 21, 2025; options have a two-year expiration from each vesting date (per filing).
  • Shares owned after the transaction are not specified in the provided data.

Context

  • This was an option exercise followed by immediate sales (common “exercise-and-sell” / cashless-like outcome): the insider realized the difference between market price and strike prices.
  • Sales executed under a 10b5-1 plan are pre-arranged trading programs that can indicate trades were planned in advance, not necessarily a contemporaneous signal about the insider’s view.
  • The filing is factual and timely; it documents routine monetization of vested equity rather than an additional purchase (which retail investors often view as a stronger bullish signal).

Insider Transaction Report

Form 4
Period: 2026-03-05
Davies Philip D
DirectorVP Global Sales & Marketing
Transactions
  • Exercise/Conversion

    Common Stock

    2026-03-05$41.61/sh+1,920$79,8913,840 total
  • Exercise/Conversion

    Common Stock

    2026-03-05$60.61/sh+2,585$156,6776,425 total
  • Exercise/Conversion

    Common Stock

    2026-03-05$75.43/sh+914$68,9437,339 total
  • Sale

    Common Stock

    [F1][F2]
    2026-03-05$177.18/sh100$17,7187,239 total
  • Sale

    Common Stock

    [F1][F3]
    2026-03-05$179.38/sh700$125,5676,539 total
  • Sale

    Common Stock

    [F1][F4]
    2026-03-05$180.24/sh607$109,4045,932 total
  • Sale

    Common Stock

    [F1][F5]
    2026-03-05$181.49/sh698$126,6795,234 total
  • Sale

    Common Stock

    [F1][F6]
    2026-03-05$182.17/sh100$18,2175,134 total
  • Sale

    Common Stock

    [F1][F7]
    2026-03-05$185.51/sh100$18,5515,034 total
  • Sale

    Common Stock

    [F1][F8]
    2026-03-05$187.26/sh300$56,1774,734 total
  • Sale

    Common Stock

    [F1][F9]
    2026-03-05$189.21/sh300$56,7624,434 total
  • Sale

    Common Stock

    [F1][F10]
    2026-03-05$193.12/sh300$57,9364,134 total
  • Sale

    Common Stock

    [F1][F11]
    2026-03-05$194.98/sh300$58,4943,834 total
  • Sale

    Common Stock

    [F1][F12]
    2026-03-05$196.45/sh100$19,6453,734 total
  • Sale

    Common Stock

    [F1][F13]
    2026-03-05$199.49/sh1,514$302,0242,220 total
  • Sale

    Common Stock

    [F1][F14]
    2026-03-05$202.18/sh300$60,6551,920 total
  • Exercise/Conversion

    Non Qualified Stock Option

    [F15]
    2026-03-051,92015,358 total
    Exercise: $41.61From: 2025-05-02Common Stock (1,920 underlying)
  • Exercise/Conversion

    Non Qualified Stock Option

    [F15]
    2026-03-052,5857,752 total
    Exercise: $60.61From: 2025-04-25Common Stock (2,585 underlying)
  • Exercise/Conversion

    Non Qualified Stock Option

    [F15]
    2026-03-059141,827 total
    Exercise: $75.43From: 2025-05-12Common Stock (914 underlying)
Footnotes (15)
  • [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2025.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.9800 to $193.1900
  • [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.9500 to $195.0000.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $196.4500 to $196.4500.
  • [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $199.4200 to $199.7200.
  • [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $202.1100 to $202.2600
  • [F15]Options expire 2 years from each date of vesting.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.1800 to $177.1800.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $178.7900 to $179.7700.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $180.0500 to $181.0100.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.1600 to $181.9400.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $182.1700 to $182.1700.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $185.5100 to $185.5100.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.9200 to $187.8800.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.0600 to $189.4800.
Signature
/s/Quentin A. Fendelet Attorney in fact for Philip D. Davies|2026-03-05

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT